- Home
- CHMI vs OKYO Comparison
CHMI vs OKYO Comparison
Compare CHMI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHMI | OKYO |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United Kingdom |
| Employees | 14 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 85.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CHMI | OKYO |
|---|---|---|
| Price | $2.50 | $1.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.00 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 234.8K | 77.1K |
| Earning Date | 05-05-2026 | 07-18-2025 |
| Dividend Yield | ★ 15.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $59.20 | N/A |
| P/E Ratio | $139.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.17 | $1.03 |
| 52 Week High | $3.14 | $3.35 |
Technical Indicators
Market Signals| Indicator | CHMI | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 50.48 |
| Support Level | $2.52 | $1.53 |
| Resistance Level | $2.74 | $1.74 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 32.50 | 82.76 |
Price Performance
Historical ComparisonAbout CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.